{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:10:45Z","timestamp":1790158245753,"version":"4.1.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    Aging and neurodegenerative disorders (NDDs) are intricately linked to a gradual deterioration in nicotinamide adenine dinucleotide (NAD\n                    <jats:sup>+<\/jats:sup>\n                    ) metabolism, compromised mitochondrial functionality, persistent inflammation, and modified gut\u2013brain interactions. Derivatives of vitamin B3, such as niacin, nicotinamide, nicotinamide riboside, and nicotinamide mononucleotide, have been identified as pivotal NAD\n                    <jats:sup>+<\/jats:sup>\n                    precursors that possess the potential to support cellular bioenergetic processes and modulate pathways associated with brain aging. Evidence from preclinical studies and emerging clinical investigations suggests that NAD\n                    <jats:sup>+<\/jats:sup>\n                    -enhancing interventions may improve mitochondrial function and modulate neuroinflammatory pathways, thereby supporting cellular processes involved in synaptic plasticity and cognitive function; however, their long-term efficacy and clinical relevance in NDDs remain to be fully established. Concurrently, physical exercise serves as a robust physiological stimulus that augments NAD\n                    <jats:sup>+<\/jats:sup>\n                    biosynthesis, modulates hypoxia-inducible factor-1\u03b1-dependent adaptive responses, fosters neurotrophic signaling, and enhances both vascular and metabolic health of the brain. Furthermore, emerging evidence suggests that the gut microbiota directly contributes to NAD\n                    <jats:sup>+<\/jats:sup>\n                    homeostasis by regulating vitamin B3 precursor availability, tryptophan metabolism, and host metabolic signaling, while also influencing the efficacy of NAD\n                    <jats:sup>+<\/jats:sup>\n                    -enhancing interventions, thereby affecting systemic inflammation, metabolic equilibrium, and the production of neuroactive metabolites. Collectively, the interaction among vitamin B3 supplementation, physical activity, and gut microbiota may represent a promising framework for investigating strategies aimed at supporting cognitive health and brain resilience during aging, although definitive therapeutic applications require further validation. This review integrates current molecular, preclinical, and clinical evidence to establish mechanistic links between NAD\n                    <jats:sup>+<\/jats:sup>\n                    metabolism, brain aging, cognitive dysfunction, and neurodegeneration, while emphasizing current limitations and future translational challenges associated with combining vitamin B3 metabolites, exercise, and microbiome-targeted approaches.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2026.1865556","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:33:22Z","timestamp":1790156002000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Restoring NAD+ pathways in brain aging and neurodegenerative diseases: roles of vitamin B3 metabolites, gut microbiota, and exercise in cognitive health"],"prefix":"10.3389","volume":"13","author":[{"given":"Wu","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Physical Education, Yan\u2019an University, Yan\u2019an","place":["Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging.","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12961-025-01314-y","article-title":"A scoping review of national policies for dementia prevention and control in mainland China.","volume":"23","author":"Zhang","year":"2025","journal-title":"Health Res Policy Syst"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease.","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10072-024-07941-7","article-title":"Global, regional and national temporal trends in Parkinson\u2019s disease incidence, disability-adjusted life year rates in middle-aged and older adults: a cross-national inequality analysis and Bayesian age-period-cohort analysis based on the global burden of disease 2021.","volume":"46","author":"Zhang","year":"2025","journal-title":"Neurol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD+ supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.","volume":"115","author":"Hou","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders.","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrn3085","article-title":"A pathophysiological framework of hippocampal dysfunction in ageing and disease.","volume":"12","author":"Small","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.tics.2012.04.005","article-title":"Memory aging and brain maintenance.","volume":"16","author":"Nyberg","year":"2012","journal-title":"Trends Cogn Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nn.3304","article-title":"Memory, navigation and theta rhythm in the hippocampal-entorhinal system.","volume":"16","author":"Buzs\u00e1ki","year":"2013","journal-title":"Nat Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease.","volume":"16","author":"G\u00f3mez-Isla","year":"1996","journal-title":"J Neurosci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of brain aging: adaptive and pathological modification by metabolic states.","volume":"27","author":"Mattson","year":"2018","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","article-title":"Mitochondria, energy, and metabolism in neuronal health and disease.","volume":"596","author":"Trigo","year":"2022","journal-title":"FEBS Lett"},{"key":"B14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances.","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.3390\/ijms22073574","article-title":"Improving age-related cognitive decline through dietary interventions targeting mitochondrial dysfunction.","volume":"22","author":"Kaliszewska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration.","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing.","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cmet.2025.04.002","article-title":"NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging.","volume":"37","author":"Chubanava","year":"2025","journal-title":"Cell Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.4103\/NRR.NRR-D-24-00311","article-title":"Dendritic spine degeneration: a primary mechanism in the aging process.","volume":"20","author":"Flores","year":"2025","journal-title":"Neural Regen Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-pathol-012615-044216","article-title":"Dendritic spine pathology in neurodegenerative diseases.","volume":"11","author":"Herms","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2004.11.003","article-title":"The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.","volume":"119","author":"Li","year":"2004","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1113\/JP286859","article-title":"Spine apparatus modulates Ca2+ in spines through spatial localization of sources and sinks.","volume":"603","author":"Hern\u00e1ndez Mesa","year":"2025","journal-title":"J Physiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in vivo evidence.","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","article-title":"NAD+ in aging: molecular mechanisms and translational implications.","volume":"23","author":"Fang","year":"2017","journal-title":"Trends Mol Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus.","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","article-title":"Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.","volume":"28","author":"Bogan","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/fft2.511","article-title":"An updated review on the mechanisms, pre-clinical and clinical comparisons of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR).","volume":"6","author":"Yang","year":"2025","journal-title":"Food Front"},{"key":"B29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/ijms20040974","article-title":"Niacin in the central nervous system: an update of biological aspects and clinical applications.","volume":"20","author":"Gasperi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00018-025-05836-0","article-title":"The role of the SIRT1 and mTOR pathways in exercise-induced \u03b2-cell senescence reduction in type 2 diabetes mellitus.","volume":"82","author":"Hoseini","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B31","volume-title":"Exercise and Non-Pharmacological Interventions to Improve Metabolic Health and Well-Being in Chronic Conditions.","author":"Della Guardia","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroscience.2015.03.015","article-title":"HIF1\u03b1 is necessary for exercise-induced neuroprotection while HIF2\u03b1 is needed for dopaminergic neuron survival in the substantia nigra pars compacta.","volume":"295","author":"Smeyne","year":"2015","journal-title":"Neuroscience"},{"key":"B33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/nu13030732","article-title":"The role of gut bacterial metabolites in brain development, aging and disease.","volume":"13","author":"Tran","year":"2021","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease.","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD+ intermediates: the biology and therapeutic potential of NMN and NR.","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmet.2021.04.003","article-title":"Evolving concepts in NAD+ metabolism.","volume":"33","author":"Chini","year":"2021","journal-title":"Cell Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration.","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD+ homeostasis in health and disease.","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12264-023-01072-3","article-title":"Targeting NAD metabolism for the therapy of age-related neurodegenerative diseases.","volume":"40","author":"Li","year":"2024","journal-title":"Neurosci Bull"},{"key":"B40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-814118-2.00008-2","article-title":"NAD+: a crucial regulator of sirtuin activity in aging.","volume-title":"Sirtuin Biology in Medicine.","author":"Braidy","year":"2021"},{"key":"B41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fendo.2018.00702","article-title":"Brain SIRT1 mediates metabolic homeostasis and neuroprotection.","volume":"9","author":"Xu","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival.","volume":"30","author":"Murata","year":"2019","journal-title":"Mol Biol Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3390\/ijms24032959","article-title":"The central role of the NAD+ molecule in the development of aging and the prevention of chronic age-related diseases: strategies for NAD+ modulation.","volume":"24","author":"Polj\u0161ak","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2741\/2194","article-title":"NAD+ and NADH in brain functions, brain diseases and brain aging.","volume":"12","author":"Ying","year":"2007","journal-title":"Front Biosci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/metabo10110450","article-title":"Energy metabolism decline in the aging brain-pathogenesis of neurodegenerative disorders.","volume":"10","author":"B\u0142aszczyk","year":"2020","journal-title":"Metabolites"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/biomedicines10102434","article-title":"Role of sirtuins in physiology and diseases of the central nervous system.","volume":"10","author":"Chojdak-\u0141ukasiewicz","year":"2022","journal-title":"Biomedicines"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9240","DOI":"10.1007\/s12035-025-04835-3","article-title":"SARM1: the checkpoint of axonal degeneration in the nervous system disorders.","volume":"62","author":"Karnik","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1210\/er.2009-0026","article-title":"The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.","volume":"31","author":"Houtkooper","year":"2010","journal-title":"Endocr Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e13921","DOI":"10.1111\/apha.13921","article-title":"Tissue-specific effects of exercise as NAD+-boosting strategy: current knowledge and future perspectives.","volume":"237","author":"Walzik","year":"2023","journal-title":"Acta Physiol (Oxf)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"E308","DOI":"10.1152\/ajpendo.00054.2012","article-title":"NAD(+)\/NADH and skeletal muscle mitochondrial adaptations to exercise.","volume":"303","author":"White","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/WNR.0000000000001239","article-title":"Intensive treadmill exercise increases expression of hypoxia-inducible factor 1\u03b1 and its downstream transcript targets: a potential role in neuroplasticity.","volume":"30","author":"Halliday","year":"2019","journal-title":"Neuroreport"},{"key":"B52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13037-025-00453-z","article-title":"Hypoxia-inducible factor 1-alpha (HIF1\u03b1), nicotinamide adenine dinucleotide (NAD+, NADH), and nitric oxide (NO) interplay in critically ill patients, with implications for patient safety and targeted therapies: a review.","volume":"19","author":"Bar-Or","year":"2025","journal-title":"Patient Saf Surg"},{"key":"B53","volume-title":"Boosting NAD<sup>+<\/sup> for Anti-Aging: Mechanisms, Interventions, and Opportunities.","author":"Alpay","year":"2025"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/ars.2023.0295","article-title":"Sirtuins: the NAD+-dependent multifaceted modulators of inflammation.","volume":"39","author":"Santos","year":"2023","journal-title":"Antioxid Redox Signal"},{"key":"B55","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms252312924","article-title":"The BDNF-interactive model for sustainable hippocampal neurogenesis in humans: synergistic effects of environmentally-mediated physical activity, cognitive stimulation, and mindfulness.","volume":"25","author":"Khalil","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms26094271","article-title":"From synaptic plasticity to neurodegeneration: BDNF as a transformative target in medicine.","volume":"26","author":"Toader","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.3390\/ijms22115795","article-title":"Physical exercise-induced myokines in neurodegenerative diseases.","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B58","volume-title":"Dementia and Physical Activity: Exploring the Effects of Physical Activity on Cognitive Function in Persons with Dementia and Investigating Mediating Factors for Successful Implementation of Physical Activity Strategies.","author":"Cardona Cardona","year":"2024"},{"key":"B59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/life14050597","article-title":"The role of physical activity in adjunctive nursing management of neuro-degenerative diseases among older adults: a systematic review of interventional studies.","volume":"14","author":"Alanazi","year":"2024","journal-title":"Life (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11011-020-00646-8","article-title":"Physical exercise prevents amyloid \u03b21-40-induced disturbances in NLRP3 inflammasome pathway in the hippocampus of mice.","volume":"36","author":"Rosa","year":"2021","journal-title":"Metab Brain Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40798-025-00857-2","article-title":"Physical activity to counter age-related cognitive decline: benefits of aerobic, resistance, and combined training-a narrative review.","volume":"11","author":"Dhahbi","year":"2025","journal-title":"Sports Med Open"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s11357-025-01793-5","article-title":"Nicotinamide riboside treatment enhances stress sensitivity and modulates hematological dynamics in aged mice.","volume":"48","author":"Culig","year":"2026","journal-title":"Geroscience"},{"key":"B63","doi-asserted-by":"publisher","first-page":"103607","DOI":"10.1016\/j.jpet.2025.103607","article-title":"Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: results from a pilot 4-week open-label clinical trial.","volume":"392","author":"Szarvas","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e70004","DOI":"10.1111\/acel.70004","article-title":"Nicotinamide riboside supplementation alleviates testicular aging induced by disruption of Qprt-dependent NAD+ de novo synthesis in mice.","volume":"24","author":"Xu","year":"2025","journal-title":"Aging Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"glae303","DOI":"10.1093\/gerona\/glae303","article-title":"Nicotinamide prevents the plasticity impairments and the cognitive dysfunction caused by bone fracture in older mice.","volume":"80","author":"Guncay","year":"2025","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/s10815-024-03263-x","article-title":"The NAD+ precursor nicotinamide riboside protects against postovulatory aging in vitro.","volume":"41","author":"Li","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e13754","DOI":"10.1111\/acel.13754","article-title":"Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin.","volume":"22","author":"Vreones","year":"2023","journal-title":"Aging Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"111189","DOI":"10.1016\/j.nut.2021.111189","article-title":"Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors.","volume":"8","author":"Seldeen","year":"2021","journal-title":"Nutrition"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e12935","DOI":"10.1111\/acel.12935","article-title":"NAD+ supplementation rejuvenates aged gut adult stem cells.","volume":"18","author":"Igarashi","year":"2019","journal-title":"Aging Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11357-023-00999-9","article-title":"A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment.","volume":"46","author":"Orr","year":"2024","journal-title":"Geroscience"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.","volume":"9","author":"Martens","year":"2018","journal-title":"Nat Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e70023","DOI":"10.1002\/trc2.70023","article-title":"Cognitive and Alzheimer\u2019s disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment.","volume":"11","author":"Wu","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes.","volume":"27","author":"Liu","year":"2018","journal-title":"Cell Metab"},{"key":"B74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41514-022-00084-z","article-title":"Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.","volume":"8","author":"Igarashi","year":"2022","journal-title":"NPJ Aging"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures.","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0186459","DOI":"10.1371\/journal.pone.0186459","article-title":"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.","volume":"12","author":"Airhart","year":"2017","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.celrep.2018.05.009","article-title":"The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson\u2019s disease.","volume":"23","author":"Sch\u00f6ndorf","year":"2018","journal-title":"Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1507\/endocrj.EJ19-0313","article-title":"Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.","volume":"67","author":"Irie","year":"2020","journal-title":"Endocr J"},{"key":"B79","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases.","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","article-title":"Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice.","volume":"24","author":"Mills","year":"2016","journal-title":"Cell Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dnarep.2014.09.004","article-title":"ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death.","volume":"23","author":"Fouquerel","year":"2014","journal-title":"DNA Repair (Amst)"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.21037\/atm-22-1148","article-title":"Nicotinic acid supplementation contributes to the amelioration of Alzheimer\u2019s disease in mouse models.","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","article-title":"NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS-STING.","volume":"118","author":"Hou","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B84","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11011-018-0346-8","article-title":"Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer\u2019s disease model mice.","volume":"34","author":"Xie","year":"2019","journal-title":"Metab Brain Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1177\/13872877261422502","article-title":"Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer\u2019s disease pathology in APP\/PS1 mice.","volume":"110","author":"Zhou","year":"2026","journal-title":"J Alzheimers Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e16295","DOI":"10.1111\/jnc.16295","article-title":"Effect of dietary ketosis and nicotinamide riboside on hippocampal Krebs cycle intermediates and mitochondrial energetics in a DNA repair-deficient 3xTg\/POL\u03b2+\/- Alzheimer disease mouse model.","volume":"169","author":"Pawlosky","year":"2025","journal-title":"J Neurochem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41419-024-07062-1","article-title":"NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer\u2019s disease via ATF4-dependent mitochondrial UPR.","volume":"15","author":"Xiong","year":"2024","journal-title":"Cell Death Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"117199","DOI":"10.1016\/j.biopha.2024.117199","article-title":"Therapeutic effect of nicotinamide mononucleotide on Alzheimer\u2019s disease through activating autophagy and anti-oxidative stress.","volume":"178","author":"Ma","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B89","doi-asserted-by":"publisher","first-page":"993615","DOI":"10.3389\/fnagi.2022.993615","article-title":"Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer\u2019s mouse model.","volume":"14","author":"Chu","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease.","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease.","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/biomedicines9121881","article-title":"Low-dose niacin supplementation improves motor function in US veterans with Parkinson\u2019s disease: a single-center, randomized, placebo-controlled trial.","volume":"9","author":"Wakade","year":"2021","journal-title":"Biomedicines"},{"key":"B93","doi-asserted-by":"publisher","first-page":"106278","DOI":"10.1016\/j.isci.2023.106278","article-title":"Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson\u2019s disease.","volume":"26","author":"Gaare","year":"2023","journal-title":"iScience"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/jnr.21650","article-title":"High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson\u2019s disease.","volume":"86","author":"Jia","year":"2008","journal-title":"J Neurosci Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3390\/biomedicines10112929","article-title":"Neuroprotective effects of nicotinamide against MPTP-induced Parkinson\u2019s disease in mice: impact on oxidative stress, neuroinflammation, Nrf2\/HO-1 and TLR4 signaling pathways.","volume":"10","author":"Rehman","year":"2022","journal-title":"Biomedicines"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e34355","DOI":"10.1016\/j.heliyon.2024.e34355","article-title":"Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson\u2019s disease.","volume":"10","author":"Turconi","year":"2024","journal-title":"Heliyon"},{"key":"B97","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3892\/etm.2014.1842","article-title":"Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson\u2019s disease.","volume":"8","author":"Lu","year":"2014","journal-title":"Exp Ther Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"109670","DOI":"10.1016\/j.pnpbp.2019.109670","article-title":"Protective effects of \u03b2-nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson\u2019s disease.","volume":"94","author":"Shan","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"111118","DOI":"10.1016\/j.cbi.2024.111118","article-title":"Nicotinamide riboside ameliorates survival time and motor dysfunction in an MPTP-Induced Parkinson\u2019s disease zebrafish model through effects on glucose metabolism and endoplasmic reticulum stress.","volume":"399","author":"Luo","year":"2024","journal-title":"Chem Biol Interact"},{"key":"B100","doi-asserted-by":"publisher","first-page":"132","DOI":"10.12688\/f1000research.12120.1","article-title":"NAD+ biosynthesis, aging, and disease.","volume":"7","author":"Johnson","year":"2018","journal-title":"F1000Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1007\/s11357-025-01815-2","article-title":"Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial.","volume":"47","author":"Lin","year":"2025","journal-title":"Geroscience"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1093\/jn\/nxab193","article-title":"NAD+-precursor supplementation with L-tryptophan, nicotinic acid, and nicotinamide does not affect mitochondrial function or skeletal muscle function in physically compromised older adults.","volume":"151","author":"Connell","year":"2021","journal-title":"J Nutr"},{"key":"B103","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00394-019-01919-4","article-title":"Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study.","volume":"59","author":"Dolopikou","year":"2020","journal-title":"Eur J Nutr"},{"key":"B104","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10522-017-9705-9","article-title":"Exogenous nicotinamide supplementation and moderate physical exercise can attenuate the aging process in skeletal muscle of rats.","volume":"18","author":"Pajk","year":"2017","journal-title":"Biogerontology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.3390\/nu17193148","article-title":"Effects of nicotinamide mononucleotide supplementation and aerobic exercise on metabolic health and physical performance in aged mice.","volume":"17","author":"Hsu","year":"2025","journal-title":"Nutrients"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.","volume":"458","author":"Cant\u00f3","year":"2009","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mad.2009.11.002","article-title":"Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats.","volume":"131","author":"Koltai","year":"2010","journal-title":"Mech Ageing Dev"},{"key":"B108","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cell.2018.02.008","article-title":"Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging.","volume":"173","author":"Das","year":"2018","journal-title":"Cell"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1865556\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:33:24Z","timestamp":1790156004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1865556\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":108,"alternative-id":["10.3389\/fnut.2026.1865556"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1865556","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1865556"}}